Related Experiment Video
Updated: Dec 21, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2
1Department of Urology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. jackyst@163.com.
Objective:
To investigate the expression of micro ribonucleic acid (miR)-219-5p in prostate cancer (PCa), its influences on the biological functions of PCa, and its mechanism.
Patients And Methods:
The expression differences of miR-219-5p and high mobility group protein A2 (HMGA2) in 30 pairs of PCa tissues and para-carcinoma tissues were detected via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR), and the difference in miR-219-5p expression in PCa cell lines and normal prostatic epithelial cells was also determined via qRT-PCR. The human PC-3 cells were divided into negative control group and miR-219-5p overexpression group. Methyl thiazolyl tetrazolium (MTT) and colony formation assays were adopted to detect the cell proliferative ability, and flow cytometry was applied to determine the cell apoptosis. The expression of apoptosis-related proteins was measured via Western blotting, and the invasive and migratory abilities of the cells were examined through wound-healing and transwell assays. Bioinformatics prediction software and luciferase reporter assay were employed to verify the targets that might be controlled by miR-219-5p. Rescue experiment was conducted to clarify whether the inhibitory effects of miR-219-5p on the growth and metastasis of PC-3 cells depend on the inhibition of HMGA2.
Results:
It was shown in qRT-PCR results that the expression level of miR-219-5p was downregulated remarkably in PCa tissues and cell lines, but overexpressed miR-219-5p could repress the proliferation and promote the apoptosis of PC-3 cells notably. The results of wound-healing and transwell assays indicated that overexpressed miR-219-5p was able to suppress the invasion and metastasis of PC-3 cells. According to Western blotting results, overexpressed miR-219-5p could up-regulate the expressions of pro-apoptotic proteins [Bax, cleaved-caspase-3 and cleaved-poly-ADP-ribose-polymerase (PARP)] and reverse the epithelial-mesenchymal transition (EMT) of PCa cells. It was predicted via the bioinformatics software that HMGA2 gene might be a target gene of miR-219-5p. The Dual-Luciferase reporter assay confirmed that there was a direct regulatory relationship between miR-219-5p and HMGA2. The rescue experiment manifested that overexpressed HMGA2 could reverse the inhibition of miR-219-5p on the growth and metastasis of PC-3 cells.
Conclusions:
MiR-219-5p suppresses the growth and metastasis abilities of prostate cancer cells by directly repressing the expression of HMGA2.
Insights
Micro ribonucleic acid (miR)-219-5p is downregulated in prostate cancer (PCa). Overexpressing miR-219-5p inhibits PCa cell growth and metastasis by targeting high mobility group protein A2 (HMGA2).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer (PCa) remains a significant health concern, necessitating research into novel therapeutic targets.
- Micro ribonucleic acids (miRNAs) play crucial roles in cancer development and progression.
- Understanding the specific functions of miRNAs like miR-219-5p in PCa is vital for developing targeted therapies.
Purpose of the Study:
- To investigate the expression levels of miR-219-5p in prostate cancer.
- To elucidate the functional impact of miR-219-5p on PCa cell biological behaviors, including proliferation, apoptosis, invasion, and metastasis.
- To identify the molecular mechanism underlying miR-219-5p's action in PCa, particularly its interaction with high mobility group protein A2 (HMGA2).
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to assess miR-219-5p and HMGA2 expression in PCa tissues and cell lines.
- In vitro assays including MTT, colony formation, flow cytometry, wound-healing, and Transwell assays to evaluate cell proliferation, apoptosis, invasion, and migration.
- Western blotting to analyze the expression of apoptosis-related proteins and epithelial-mesenchymal transition (EMT) markers.
- Bioinformatics prediction and Dual-Luciferase reporter assays to confirm the direct targeting of HMGA2 by miR-219-5p.
- Rescue experiments to validate the functional relationship between miR-219-5p and HMGA2.
Main Results:
- miR-219-5p expression was significantly downregulated in PCa tissues and cell lines compared to normal controls.
- Overexpression of miR-219-5p suppressed PCa cell proliferation, induced apoptosis, and inhibited invasion and metastasis.
- miR-219-5p overexpression upregulated pro-apoptotic proteins (Bax, cleaved-caspase-3, cleaved-PARP) and reversed EMT.
- HMGA2 was identified as a direct target of miR-219-5p, with their regulatory relationship confirmed by luciferase reporter assays.
- Rescue experiments demonstrated that HMGA2 overexpression could reverse the inhibitory effects of miR-219-5p on PCa cell growth and metastasis.
Conclusions:
- miR-219-5p acts as a tumor suppressor in prostate cancer.
- The tumor-suppressive function of miR-219-5p is mediated through the direct inhibition of high mobility group protein A2 (HMGA2) expression.
- miR-219-5p represents a potential therapeutic target for prostate cancer treatment.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

